Within cells, the process of energy metabolism occurs continuously, and the conversion between ATP (adenosine triphosphate), ADP (adenosine diphosphate) and AMP (adenosine monophosphate) is the key to maintaining life activities. Adenylate kinase (ADK), as a phosphotransferase, can catalyze the interconversion of these three nucleotides. This process plays a pivotal role in cellular energy homeostasis.
Adenylate kinase regulates cellular energy needs by continuously monitoring intracellular phosphate nucleotide levels.
The reaction catalyzed by adenylate kinase is divided into: ATP + AMP ⇔ 2 ADP. The equilibrium constant for this reaction varies with conditions, but is roughly close to 1, which means that the Gibbs free energy change of the reaction is close to zero. For the muscles of a variety of vertebrates and invertebrates, the concentration of ATP is usually 7-10 times that of ADP, and the concentration of AMP is usually more than 100 times greater. Mitochondria struggle to maintain high levels of ATP due to the control mechanisms of ADK and oxidative phosphorylation.
Nine ADK protein isoenzymes have been identified in humans. Some of them are widespread throughout the body, while others are restricted to specific tissues. For example, ADK7 and ADK8 are found only in the cytoplasm of cells, with ADK7 expressed in skeletal muscle but ADK8 not. Each isoenzyme not only differs in its location within the cell, but also in its kinetics of substrate binding and phosphotransfer. ADK1 is the most abundant cytoplasmic ADK isoenzyme, and its affinity for AMP is approximately a thousand times weaker than ADK7 and ADK8.
Some ADK isoenzymes use only ATP, while other isoenzymes can accept GTP, UTP, and CTP as phosphate carriers.
The catalytic process of adenylate kinase only occurs after the "open lid" is closed. This process excludes water molecules, allowing the substrates to approach each other, lowering the energy barrier for AMP to carry out nucleophilic attack on the γ-phosphate group of ATP, thereby forming ADP. Studies have shown that the interaction between certain key residues such as Arg88 and phosphorylated substrates is critical.
The existence of ADK enables cells to dynamically monitor energy levels. By constantly adjusting the ratio of ATP, ADP and AMP, ADK can regulate the energy expenditure of cells. Under various metabolic stresses, ADK instantly generates AMP. As a signaling molecule, AMP can further stimulate a variety of AMP-dependent receptors, thereby affecting the metabolic process of cells.
In cell studies, defects in adenylate kinase are associated with a variety of diseases. For example, NDP kinase deficiency causes adenylate kinase to exhibit dual enzymatic functions. In addition, AK1 deficiency leads to metabolic disorders after myocardial ischemia, while ADK2 deficiency is associated with blood cell defects and deafness.
These biological findings highlight the critical role of adenylate kinase in cellular energy metabolism.
The existence of adenylate kinase is not limited to humans, it has also been confirmed in different bacteria and yeast, which fully illustrates the universality and importance of this enzyme in life processes. Deletion of adenylate kinase in plastic plants was also found to be associated with enhanced growth and production of photosynthetic amino acids.
Whether in energy production, cell signaling, or protection against metabolic stress, adenylate kinase plays an indispensable role. In the future, with the development of science and technology, we are looking forward to how to innovatively use this biological knowledge to treat diseases. So, how will the future application of adenylate kinase in biomedicine change our concept of health?